Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 47.25
-0.95 (-1.97%)
Mar 23, 2026, 1:12 PM CET
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 649.32 million as of March 23, 2026. Its market cap has increased by 37.32% in one year.
Market Cap
649.32M
Enterprise Value
505.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
47.25
Market Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 649.32M, an increase of 246.32%. That is a compound annual growth rate of 13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 649.32M | -4.55% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 1.31B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |
| Genovis AB (publ.) | 1.07B |
| Cantargia AB | 959.64M |
| SynAct Pharma AB | 945.31M |
| FluoGuide | 712.83M |
| Corline Biomedical AB | 405.97M |